Compare INVH & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVH | BAX |
|---|---|---|
| Founded | 2012 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 13.4B |
| IPO Year | 2016 | 1994 |
| Metric | INVH | BAX |
|---|---|---|
| Price | $26.23 | $25.39 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 25 | 15 |
| Target Price | ★ $32.57 | $27.25 |
| AVG Volume (30 Days) | 5.1M | ★ 6.3M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 4.60% | 0.16% |
| EPS Growth | ★ 29.73 | N/A |
| EPS | ★ 0.90 | 0.78 |
| Revenue | $2,729,296,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $8.37 | $4.27 |
| Revenue Next Year | $1.21 | $2.01 |
| P/E Ratio | ★ $28.99 | $32.53 |
| Revenue Growth | 4.21 | ★ 5.72 |
| 52 Week Low | $24.25 | $15.73 |
| 52 Week High | $30.89 | $30.00 |
| Indicator | INVH | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 50.29 |
| Support Level | $26.04 | $22.53 |
| Resistance Level | $27.06 | $25.99 |
| Average True Range (ATR) | 0.53 | 1.01 |
| MACD | -0.08 | -0.06 |
| Stochastic Oscillator | 24.51 | 46.78 |
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price of around $375,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth, with two-thirds of the portfolio in the Western US and Florida; 15 of the 17 markets feature average rents lower than homeownership costs.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.